193 filings
Page 6 of 10
6-K
6frux5r8
18 May 18
Affimed Announces Annual General Meeting of Shareholders
4:17pm
6-K
wq4fzvpbv0881k2t
15 May 18
Index to Condensed Consolidated Financial Statements
7:48am
6-K
escx ct2xe
20 Mar 18
Affimed Reports Financial Results for Fourth Quarter
12:00am
6-K
b4r6131cgr ia
8 Mar 18
Transforming Immuno - Oncology Using Next - Generation Immune Cell Engagers Corporate Presentation March 2018
12:00am
6-K
09ez7gx2osntj9qwvo
15 Feb 18
Current report (foreign)
12:00am
424B5
w2q80ztf o1
14 Feb 18
Prospectus supplement for primary offering
12:00am
424B5
76x74t176hk 3h50
12 Feb 18
Prospectus supplement for primary offering
12:00am
6-K
1jnhwueyrd2cp8j
1 Feb 18
Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas
12:00am
6-K
eujd02u8sskih
5 Jan 18
Transforming Immuno - Oncology Using Next - Generation Immune Cell Engagers Corporate Presentation January 2018
12:00am
6-K
74l5tq1nlxob2is4
7 Nov 17
Index to Condensed Consolidated Financial Statements
12:00am
6-K
vhzhc8bbe p3cfj2dw
13 Sep 17
Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer
12:00am
6-K
ay2o askzb1hqo0
1 Aug 17
Index to Condensed Consolidated Financial Statements
12:00am
6-K
e2rnp
21 Jun 17
Current report (foreign)
12:00am
6-K
uq9bl48 m50wy
22 May 17
Affimed Announces Annual General Meeting of Shareholders
12:00am
6-K
3hn1nddp6k
17 May 17
Index to Condensed Consolidated Financial Statements
12:00am
6-K
pjyegs 05
30 Mar 17
Affimed Reports Financial Results for Fourth Quarter
12:00am
6-K/A
q1ill150dl
9 Feb 17
Current report (foreign) (amended)
12:00am
6-K
ju8gi 3xaocil
8 Feb 17
Current report (foreign)
12:00am